InnovAge Announces Financial Results For the Fiscal Second Quarter Ended December 31, 2024

Published on February 4, 2025

DENVER, Feb. 04, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today

Continue reading on website
Other news

NorstellaLinQ data source added to Atropos Evidence™ Network, scoring in the top decile for data quality on Real World Fitness Score®

February 4, 2025
Palo Alto, CA – February 4, 2025 – Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence (RWE) for care, announces the availability of an initial dataset from NorstellaLinQ on the Atropos Evidence Network. NorstellaLinQ, built by Norstella, one of the largest global pharma intelligence solution providers, is the first and only fully

iPSC-Derived Allogeneic Cell Therapies and Cloaking: Mechanisms, Importance and Strategies

February 5, 2025
Introduction Induced pluripotent stem cell (iPSC)-derived allogeneic cell therapies hold significant promise for treating a wide range of diseases by providing a renewable and scalable source of cells.